Leading Life Sciences Recruiter Reports 30% Turnover Increase

Company News | | 1 minute read.
Ryan Watson

Entrust Resource Solutions (ERS), specialist in Life Sciences and Healthcare talent acquisition, continues to see the results of an ambitious development plan as it reports a turnover increase of 30% to £5.5million.

Relating to financial year end March 2022, the same period also saw a 50% growth in headcount across the group including the creation of three new strategic roles: Group Operations Director, and two Divisional Directors.

These results are, in part, attributable to ERS’ ongoing response to the COVID-19 pandemic during 2021, which saw sector demand for its specialist resourcing services continue to increase. However, they are also indicative of a pre-pandemic predicted growth within the UK Life Sciences sector.

The company, which operates from three strategic locations across the UK, specialises in what it terms “bench to board” resourcing activity, recruiting for contract and permanent roles at all levels within the life science, healthcare, pharmaceutical and biotechnology sectors.

During 2021 the company was responsible for placing 650 personnel across the UK, with a primary focus upon the fields of technology development and manufacture, quality assurance and scientific and laboratory activity.

Chief Executive Officer, Ryan Watson, comments: “ERS continues to meet the twin challenges of a UK talent shortage and demand at all levels, not least through a commitment to diversity and cross-sector talent acquisition.

“The UK Life Sciences sector is incredibly buoyant and is forecast to remain so for the foreseeable future. A recent report by the UK Government’s Office for Life Sciences highlights seven core disease and technology areas where there is an opportunity for Government, industry, the NHS, medical research charities and academia to work together to improve treatment options and patient outcomes.

“The foundation of this opportunity lies in the provision of relevant talent, for which ERS has earned an outstanding reputation, based upon our objective to support both client and candidate at an unprecedented level.”

As the company embarks upon the new financial year, it continues to implement a robust growth strategy including the development of a training academy in collaboration with Purdue University, Indiana and closer to home, the creation of a base in Warrington, designed to accommodate a growing team whilst consolidating its existing connection with the thriving Pharmaceutical and Life Science industry across the North West and Wales.

stay connected

Latest Updates

The CDMO Landscape The contract manufacturing market in the United States is expected to reach USD 68.32 Billion by 2029, followed by China, India and Germany. Canada is also a significant market for CDMOs, expected to reach USD 7.88 Billion. What is a CDMO? A Contract Development and Manufacturing Organisation (CDMO)…


25 April 2024| Life Science News Viewpoint

We’re delighted to share some exciting news – Ronnie Anderson and Kellie Saul are gearing up for an incredible experience at the upcoming Translational Science Summit! For those who might not know, the Translational Science Summit is the epitome of innovation and collaboration in the realm of translational sciences. It’s…


16 April 2024| Events News